Carregant...
Lymph Node Status in Breast Cancer Does Not Predict Tumor Biology
BACKGROUND/OBJECTIVE. The 21-gene Oncotype DX® Breast Recurrence Score® (RS) assay has been prospectively validated as prognostic and predictive in node-negative estrogen receptor-positive (ER+)/HER2-breast cancer patients. Less is known about its prognostic role in node-positive breast cancer. We c...
Guardat en:
| Publicat a: | Ann Surg Oncol |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6123264/ https://ncbi.nlm.nih.gov/pubmed/29968028 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1245/s10434-018-6598-z |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|